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Abstract: The aim of this study was to find out the optimum combination of electroporation 
(EP) and reverse iontophoresis (RI) on noninvasive and transdermal determination of blood 
uric acid level in humans. EP is the use of high-voltage electric pulse to create nano-channels 
on the stratum corneum, temporarily and reversibly. RI is the use of small current to facilitate 
both charged and uncharged molecule transportation across the skin. It is believed that the 
  combination of these two techniques has additional benefits on the molecules’ extraction 
across the human skin. In vitro studies using porcine skin and diffusion cell have indicated 
that the optimum mode for transdermal uric acid extraction is the combination of RI with 
symmetrical biphasic direct current (current density = 0.3 mA/cm2; phase duration = 180 s) 
and EP with 10 pulses per second (voltage = 100 V/cm2; pulse width = 1 ms). This optimum 
mode was applied to six human subjects. Uric acid was successfully extracted through the 
subjects’ skin into the   collection solution. A good correlation (r2 = 0.88) between the subject’s 
blood uric acid level and uric acid concentrations in collection solutions was observed. The 
results suggest that it may be possible to noninvasively and transdermally determine blood 
uric acid levels.
Keywords: Reverse iontophoresis, electroporation, uric acid, monitoring, noninvasive, 
transdermal
Introduction
Gout is one of the most common forms of arthritis,1 affecting more than 700,000 adults 
in the UK2 and nearly three million adults in the USA,3 and accounting for almost four 
million outpatient visits every year,4 with a substantial economic burden.5 Excessive 
amounts of uric acid, known as hyperuricemia, is one of most frequent metabolism 
disturbances. Hyperuricemia and high mean serum uric acid concentrations as risk 
factors for gout have been well documented in the past decades.6 Gouty arthritis, a 
rapid onset of joint inflammation, is a complication of hyperuricemia and is precipi-
tated by deposits of uric acid crystals in the synovial fluid and synovial lining. Recent 
research has highlighted that patients with hyperuricemia and gout are at increased 
risk of morbidity and mortality related to cardiovascular disease.7 Therefore, blood 
uric acid monitoring is very important.
The routine method to determine blood uric acid level is achieved by blood 
sampling. However, this method is invasive, painful, and inconvenient. To the best 
of our knowledge, there is no noninvasive method to determine the blood uric acid 
level. Therefore, reverse iontophoresis (RI) and electroporation (EP), noninvasive 
techniques, were used in this study to transdermally and noninvasively extract uric 
acid in humans.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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RI refers to the passage of a low level of current through 
the skin to promote the transport of both charged and neutral 
molecules.8 The main mechanisms that contribute to RI are 
the electro migration of charged species to the electrode of 
opposite polarity, electroosmosis of neutral molecules to the 
cathode or anode, or a combination of both. RI across the skin 
has been investigated as a noninvasive method for clinical 
monitoring.9 Its first clinical application was the transdermal 
extraction of glucose.10 EP is the use of an intense electric 
pulse to make the cell membrane transiently porous and then 
permeable to exogenous molecules present in the surround-
ing media.11,12 EP is widely used for the loading of cells with 
drugs13,14 and the delivery of drugs into the cells of living 
tissues.15,16 Recently, EP has been used for transcutaneous 
sampling of molecules, like glucose.17 Several papers have 
reported the use of combined RI and EP to enhance the effect 
of extracting metabolites,18,19 but no papers have been found 
for the use of combined RI and EP for the extraction of uric 
acid and this was the novelty of this study. The aim of this 
study was to find out the optimum combination of EP and 
RI on noninvasive and transdermal determination of blood 
uric acid level in humans.
Materials and methods
reagents and solutions
All reagents used in this study were commercially available 
and used without further purification: phosphate buffered 
saline and uric acid were purchased from Sigma Chemical 
Company (St. Louis, MO) and uric acid assay kit (Catalog 
number: K608–100) from BioVision (Mountain View, CA). 
De-ionized water, purified by a Millipore Milli-Q UFplus 
System (Bedford, MA) was used to prepare all solutions.
equipment
The diffusion cell for in vitro studies was the same as 
  previously described (Figure 1).20 The diffusion cell for 
human studies was newly-designed in this study, with a 5 mm 
diameter for each electrode chamber and the two electrode 
chambers were 11 mm apart (Figure 2). RI and EP devices 
were also newly-designed in this study. The RI device has the 
accuracy of ± 0.01 µA on delivering current and ±0.01 ms 
on timing. The EP device has the accuracy of ±0.1 V on 
delivering voltage and ± 0.01 ms on timing. A Bio-Rad 
680 microplate reader (Bio-Rad, Hemel Hempstead, UK) 
was used for all colorimetric analysis.
Preparation of silver–silver chloride 
electrodes
Silver–silver chloride (Ag/AgCl) electrodes were used in 
both in vitro and human studies. The Ag/AgCl electrodes 
were prepared by chloridizing 99.99% pure silver wire, 
1 mm in diameter and 25 mm in length (Aldrich Chemical 
Company Inc, Milwaukee, WI), immersed in 0.1 M HCl 
solution (  Pt-cathode) for 90 minutes at an applied current 
of 314 µA.
In vitro studies
All experiments were conducted using diffusion cells, 
in which both electrode chambers were located on the 
same   surface side of a porcine skin (250 µm) obtained by 
Electroporation & reverse
iontophoresis device
Electrode chamber
Ag/AgCl electrode
300 µ1 PBS (0.1 M, pH 7.0)
Porcine skin
Acryl
Lower chamber
uric acid
0.1 M PBS (pH
7.0) with 416 µM
Silicon gaskets
Figure 1 Diffusion cell for in vitro studies.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Measurement of blood uric acid
the electrode chambers and stored in microcentrifuge tubes at 
4°C for later quantification of uric acid. The subject’s blood 
uric acid level was also measured before experiments at the 
central laboratory of the Puli Christian Hospital.
Determination of the extracted uric acid
Colorimetric assay was used to determine the amount of uric 
acid extracted through the porcine or human skin during the 
in vitro and human studies. An excellent linear relationship 
(r2 . 0.9) between uric acid concentrations and its relative 
absorbance was found, allowing the uric acid concentration 
to be calculated simply by linear regression.
statistical analysis
One-way ANOVA was used to determine whether there were 
significant differences between EP parameters within a RI 
parameter, and between RI parameters within an EP param-
eter for the uric acid extraction. Post hoc comparisons were 
made with independent samples t-tests. A linear regression 
test was used to determine the relationship between the 
subject’s blood uric acid level and uric acid concentrations 
in collection solutions. All statistical analyses were carried 
out using SPSS software (SPSS Inc., Chicago, IL), with the 
level of statistical significance set at P , 0.05.
Results and discussion
In vitro studies
In this study, 195 combinations of RI and EP were chosen 
for the transdermal uric acid extraction in order to find out 
the optimum combination of EP and RI on noninvasive 
and transdermal determination of blood uric acid level in   
humans.
Uric acid is a negatively-charged molecule and its 
molecular weight is about 168 Da. Because of its small size 
and negative charge, uric acid was expected to be transder-
mally extractable. Electromigration was expected to be the 
dominant physical factor for the uric acid extraction.
As shown in Figure 4, the application of RI, EP, or the 
combination of both could facilitate a higher uric acid extrac-
tion as compared to diffusion alone. It was found that the 
uric acid extraction increased as the phase duration of the 
  symmetrical biphasic dc (PDSBdc) increased. At 50 V/cm2, 
100 V/cm2, and 150 V/cm2 EP, uric acid extraction using 
the 180 s PDSBdc was found to be significantly higher 
(P , 0.001 in all cases) than that of protocols utilizing 0 s, 
15 s, and 30 s PDSBdc conditions. Although an independent 
samples t-test revealed no significant difference (P = 0.617) 
between uric acid extraction using the 60 s and 180 s   PDSBdc, 
Figure 2 Diffusion cell (diameter = 27 mm) for human studies. each electrode 
chamber had a diameter of 5 mm and they were 11 mm apart.
  dermatome. Both the electrode chambers and the lower 
  chamber of the   diffusion cell were filled with 0.1 M   phosphate 
buffer (pH 7.0) while the lower chamber additionally con-
tained 416 µM uric acid. Each electrode chamber contained 
a Ag/AgCl electrode. The surface area of the porcine skin 
exposed to the electrode in each chamber was 0.2 cm2 and 
the electrode chambers were 11 mm apart. Different modes 
of EP and RI (Table 1 and Figure 3) were applied via the 
Ag/AgCl electrodes. The entire content of the electrode 
chambers were removed at the end of the experiment to 
determine the amount of uric acid extracted.
human studies
Six subjects (four men and two women; mean age 45 ± 
13 years) were recruited in this study. The study was 
approved by The Institutional Review Board of National Chi 
Nan University. Informed consent was obtained from each 
subject before the experiment.
The areas of skin of the subject’s outer forearm where 
diffusion cell was to be located were prepared by briskly 
rubbing the areas for 6–8 s with alcohol preparation pads to 
remove dry skin, oils, and other contaminants. The areas were 
then allowed to dry thoroughly. Once the diffusion cell and 
Ag/AgCl electrodes were fixed in position onto the human 
forearm, 300 µl phosphate buffer (0.1 M; pH 7.0) was added 
into each electrode chamber of the diffusion cell. Then, the 
optimum combination of RI (symmetrical biphasic direct 
current (dc) with the current density of 0.3 mA/cm2 and the 
phase duration of 180 s) and EP (100 V/cm2 electric pulse 
with the pulse width of 1 ms and 10 pulses per second) was 
applied via the Ag/AgCl electrodes to the human skin. At the 
end of the experiment, phosphate buffer was pipetted from International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
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it was observed that the longer the PDSBdc, the better the 
uric acid extraction was. Therefore, 180 s PDSBdc was rec-
ommended as the optimum setting. On the other hand, the 
combination of RI and EP could facilitate a higher uric acid 
extraction as compared to RI or EP alone. This was because 
EP could create reversible nanochannels on the skin10,11 
and this could further facilitate the uric acid extraction as 
compared with RI alone. It was also found that the higher 
the voltage of the EP, the better the uric acid extraction was. 
This meant that 150 V/cm2 EP was better than 50 V/cm2 EP 
(P , 0.001 in all cases of 15 s, 30 s, 60 s, and 180 s PDSBdc), 
as 150 V/cm2 EP had relatively more energy to effectively 
create more nanochannels. On the other hand, there was no 
significant difference (P = 0.413) between the 100 V/cm2 EP 
and 150 V/cm2 EP on the uric acid extraction. 100 V/cm2 EP 
was therefore recommended as the optimum setting. Also, no 
significant difference (P = 0.552) was found between 1 ms 
and 3 ms pulse width of the EP on the uric acid extraction. 
As such, a 1 ms pulse width of the EP was recommended 
as the optimum setting because 1 ms pulse width was com-
monly used in clinic. Moreover, EP with 10 pulses per second 
facilitated significantly more uric acid extraction (P , 0.05) 
as compared with EP with 5 pulses per second. Therefore, 
EP with 10 pulses per second was recommended as the opti-
mum setting. In a nutshell, the optimum combination of RI 
and EP on uric acid extraction was as follows:
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Notes: One hundred ninety five different combinations of reverse iontophoresis and electroporation parameters were selected for the in vitro transdermal uric acid 
extraction, in order to determine the optimum combination for uric acid extraction.
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Measurement of blood uric acid
•	 RI: symmetrical biphasic dc with a current density of 
0.3 mA/cm2 and a phase duration of 180 s
•	 EP: 100 V/cm2 electric pulse with a pulse width of 1 ms 
and 10 pulses per second.
human studies
No erythema was observed on any subject’s skin after the 
application of RI and EP. In addition, no subject reported pain 
or even unpleasant feeling during or after the experiment. 
Therefore, this human study demonstrated that RI and EP 
could provide a safe, painless, and non invasive extraction 
of uric acid in humans.
In this human study, the combination of RI and EP signifi-
cantly promoted transdermal uric acid extraction, but there 
are no other human studies for data comparison. As shown in 
Figure 5, a good correlation (r2 = 0.88) between the subject’s 
blood uric acid level and uric acid concentrations in collec-
tion solutions was observed. This meant that the subject’s 
blood uric acid level could be predicted by the uric acid 
  concentrations in collection solutions using the linear regres-
Total current passage time (13 min)
Half of the total 
current passage time
Half of the total 
current passage time
Beginning of
experiment
Middle of
experiment
End of
experiment
Reverse Iontophoresis (6 min)
(Symmetrical biphasic dc with
the phase duration of 15 s, 30 s,
60 s and 180 s)
Electroporation (30 s)
(Polarity reversing
every 15 s)
Electroporation (30 s)
(Polarity reversing
every 15 s)
Reverse Iontophoresis (6 min)
(Symmetrical biphasic dc with
the phase duration of 15 s, 30 s,
60 s and 180 s)
Sample 
collection
Figure 3 experimental protocol showing the time sequence for the application of electroporation, reverse iontophoresis, and sample collection.
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Figure 4 In vitro studies of the transdermal and noninvasive extraction of uric acid by different combinations of reverse iontophoresis (rI) and electroporation (eP). For the 
rI setting, it was a symmetrical biphasic dc with the current density of 0.3 mA/cm2. The legend shows the electroporation setting where PW and P/s are the pulse width and 
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sion equation. Therefore, a transdermal and noninvasive 
method for blood uric acid monitoring was established.
Despite promising early results, the correlation between 
the subject’s blood uric acid level and uric acid concentration 
in the collection solution was still not too high. Hence, it is 
necessary to test this method using larger subject groups in 
order to achieve a better correlation between the subject’s 
blood uric acid level and uric acid concentration in the col-
lection solution. On the other hand, subjects with a large 
difference of blood uric acid level are expected to improve 
the correlation as well.
Conclusion
Uric acid could be transdermally and noninvasively extracted 
by the combination of RI and EP. The optimum mode was 
the combination of the RI with symmetrical biphasic dc 
(current density = 0.3 mA/cm2; phase duration = 180 s) and 
EP with 10 pulses per second (voltage = 100V/cm2; pulse 
width = 1 ms). A good correlation between the subject’s 
blood uric acid level and uric acid concentrations in collec-
tion solutions was observed. Therefore, a transdermal and 
noninvasive method for blood uric acid monitoring was 
established.
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